Entrada Therapeutics
Aims to treat devastating diseases through the intracellular delivery of biologics.
Launch date
Employees
Market cap
$552m
Enterprise valuation
$147m (Public information from Sep 2024)
Share price
$15 TRDA
Boston Massachusetts (HQ)
Authorizing premium user...